Isaak Effendy

Isaak Effendy

Auto-generated profile, based on publicly available information

Isaak Effendy

MVZ – Dermatologie Franziskus Hospital Bielefeld Bielefeld Deutschland

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2022 in Journal of Health, Population and Nutrition
Verified
Journal Article
Open access
PDF file
MUMenul Ayu Umborowati
Menul Ayu Umborowati
DDDamayanti Damayanti
Damayanti Damayanti
SASylvia Anggraeni
Sylvia Anggraeni
AEAnang Endaryanto
Anang Endaryanto
ISIngrid Suryanti Surono
Ingrid Suryanti Surono
CPCita Rosita Sigit Prakoeswa
Cita Rosita Sigit Prakoeswa
Background: Atopic dermatitis (AD) is chronic inflammatory skin disease that is relapsing and a serious condition that disrupts the quality of life of affected individuals. Probiotics are an immunomodulator that can enhance the immune control of atopic dermatitis. Methods: All randomized controlled trials of probiotics for the treatment of adult AD published before December 2020 were included in this study from the PubMed databases and manual searching. Results: Six randomized controlled trials (n = 241) were selected for this meta-analysis study. Probiotics were effective in treating adult patients with AD, indicated by the decrease in Scoring Atopic Dermatitis/SCORAD (Mean Difference (MD) − 7.90, 95% CI − 7.25 to − 6.92; p < 0.00001; I2 = 96%) and improved quality of life (MD − 7.68, 95% CI − 14.08 to − 1.29; p = 0.02; I2 = 47%) which were statistically significant. However, skin severity, itch severity, Dermatology Life Quality Index (DLQI), IL-4, TFN-γ, and IgE showed no significant difference in this meta-analysis study (p > 0.05). Limitations: The study found no available data for side effects of probiotics. Strength: This meta-analysis analyzed a total of 241 AD patients of Asian and European origin. Conclusion: The use of probiotics decreased SCORAD significantly in adult patients with AD. Probiotics can improve the quality of life of patients with AD. Capsule summary: The use of probiotics in atopic dermatitis has been widely studied, with controversial results. This meta-analysis suggests that the use of probiotics can improve SCORAD and the quality of life of patients with atopic dermatitis.

23 January 2023 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
PDF file
EWElke Weisshaar
Elke Weisshaar
PBPhilipp Bentz
Philipp Bentz
CAChristian Apfelbacher
Christian Apfelbacher
EHEva Haufe
Eva Haufe
LHLuise Heinrich
Luise Heinrich
JSJochen Schmitt
Jochen Schmitt
TREATgermany is an investigator-initiated prospective disease registry. It investigates physician- and patient-reported disease severity (Eczema Area and Severity Index (EASI), objective Scoring Atopic Dermatitis (oSCORAD), Investigator Global Assessment, Patient-Oriented Eczema Measure (POEM), Patient Global Assessment (PGA)), patient-reported symptoms (itch, sleep loss, depressive symptoms), therapy courses and dermatological quality of life (DLQI) in moderate-to-severe atopic dermatitis with SCORAD > 20. 1,134 atopic dermatitis patients (mean age 41.0 ± 14.7 years, 42.5% females) were enrolled by 40 German recruiting sites (dermatological clinics and practices) between June 2016 and April 2021. The current analysis focuses on itch scores obtained with a numerical rating scale (NRS)) documented for the previous 3 days prior to baseline visit. The results show that 97.2% (1,090 of 1,121) patients experienced itch. Itch severity correlated moderately with severity of atopic dermatitis oSCORAD (rho = 0.44 (0.39–0.48)) and EASI score (rho = 0.41 (0.36–0.46)). A strong correlation was found with self-reported disease severity as PGA (rho = 0.68 (0.65–0.71)), POEM sum score (rho = 0.66 (0.63–0.69)) and dermatological quality of life impairment DLQI (rho = 0.61 (0.57–0.65)). Itch as a subjective complaint is more closely correlated with patient-reported outcomes than with objective assessments by the physician.

3 April 2021 in Journal of Dermatological Treatment
Verified
Journal Article
Closed access
BSBardur Sigurgeirsson
Bardur Sigurgeirsson
KSKnut Schäkel
Knut Schäkel
CHChih-Ho Hong
Chih-Ho Hong
IEIsaak Effendy
Isaak Effendy
WPWaldemar Placek
Waldemar Placek
MPManmath Patekar
Manmath Patekar
Evidence shows good tolerability in patients for subcutaneous injection volumes up to 3 mL.We investigated efficacy, pharmacokinetics, and tolerability of secukinumab 300 mg/2 mL pre-filled syringe...

3 February 2012 in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Verified
Journal Article
Open access
PDF file
NBNina Van Beek
Nina Van Beek
DRDiana Knuth- Rehr
Diana Knuth- Rehr
PAPeter Altmeyer
Peter Altmeyer
Chalid AssafChalid Assaf
Chalid Assaf
PBPhilipp Babilas
Philipp Babilas
ESEnno Schmidt
Enno Schmidt
Background: No consistent data are available on the currently employed diagnostic tools for autoimmune bullous diseases in Germany. The aim of this survey was to describe currently performed diagnostic methods for bullous autoimmune diseases in German dermatology departments. Methods: A standardized questionnaire evaluated the available diagnostic methods i. e. direct immunofluorescence microscopy (IFM), indirect IFM, commercial ELISA systems, and non-commercial serological tests as well as the number of samples per year in all 34 university and 39 non-university dermatology departments. Results: The overall return rate was 89 %, 100 % and 79 % for the university and non-university departments, respectively. Direct IFM was the most frequently used method and was applied in 98 % of the responding departments. In 74 % of the responding departments, indirect IFM was used mainly on monkey esophagus and human salt-split skin. Commercial ELISA systems were employed in 58 % of the clinics; all of them used anti-desmoglein ELISA, while anti-BP180 and anti-BP230 ELISA were established in 49 % and 48 % of departments, respectively. Non-commercial analytic methods were only performed in 22 % of the departments. Conclusions: The high return rate of this survey allows a relatively precise description of the current diagnostic methods used in German dermatology departments. Standard diagnostic tests are available nationwide and in bullous pemphigoid and pemphigus, the antigen-specific detection of autoantibodies is routinely performed in half of the departments. Rare disorders may be diagnosed by cooperation with some specialized centers.

18 September 1996 in Die Dermatologie
Verified
Journal Article
Closed access
PDF file
HLHarald Löffler
Harald Löffler
IEIsaak Effendy
Isaak Effendy
RHRudolf Happle
Rudolf Happle

24 August 2020 in Dermatology and Therapy
Verified
Journal Article
Open access
PDF file
KKKatharina M. Kreutzer
Katharina M. Kreutzer
IEIsaak Effendy
Isaak Effendy
Folliculotropic mycosis fungoides (FMF) is a particular subtype of mycosis fungoides (MF), characterized by an infiltration of neoplastic CD4+ T cells in the epidermis which can spread to all follicular structures, sebaceous glands, sweat glands and hair follicles. Clinically, FMF can exhibit various cutaneous symptoms. However, these symptoms often occur on the scalp, face and neck, which are rarely affected by conventional MF. We report cicatricial alopecia in a patient with FMF as alopecia lymphomatica. This peculiar symptom should be kept in mind as a critical differential diagnosis of scarring alopecia, leading to further investigation. Thus, an early diagnosis of FMF may be obtained.